I am just thinking that Pfizer knows that Maraviroc is really not big competition to Leronlimab but they spending a lot of money for studies with HIV , cancers , post stroke etc,...
Maybe they doing that thinking of Leronlimab and how much it is worth to them..
I will not be surprise really...

Why otherwise spend all this money for other company-cydy to benefit ....